Page 505 - Hematology_ Basic Principles and Practice ( PDFDrive )
P. 505

C H A P T E R          32 

                                   ACQUIRED DISORDERS OF RED CELL, WHITE CELL, AND 

                                                                                 PLATELET PRODUCTION


                                                                Jaroslaw P. Maciejewski and Swapna Thota










            ACQUIRED PURE RED CELL APLASIA                        The  inhibitory  activity  is  localized  to  the  immunoglobulin  (Ig)G
                                                                  fraction  and  disappears  upon  remission. The  antigenic  targets  for
            Acquired pure red cell aplasia (PRCA) is characterized by the presence   autoantibodies have not been well characterized, but various stages
            of  an  acquired  severe  normochromic,  most  frequently  normocytic   of erythroid differentiation can be affected (also called PRCA type
            anemia associated with a complete disappearance of reticulocytes and   A),  as  seen  in  the  reduction  of  burst-forming  unit–erythroid  or
            erythroid  precursors  in  the  marrow  and  normal  production  of   colony-forming unit–erythroid. In certain cases of antibody-mediated
            myeloid  cells  and  platelets.  Consequently,  it  is  presumed  that  the   PRCA, the involvement of the complement system is a prerequisite
            defect lies within erythroid precursors and not within stem cells as   to disease causation. Perhaps the exception and a model for antibody-
            seen in aplastic anemia. Initially described as progressive anemia with   induced red cell aplasia is the identification of PRCA associated with
            exclusive absence of erythroid series in the bone marrow, PRCA is a rare   antierythropoietin antibodies (also called PRCA type B) in rare cases.
            bone marrow failure disorder without geographic or racial predilec-  Consistent  with  the  specificity  of  the  antibodies,  myeloid  colony
            tion. All ages can be affected, but if present in children, it is called   formation is not impaired, making it unlikely that a more ubiquitous
            transient erythroblastopenia of childhood (TEC) and may be difficult   inhibitory cytokine mediates the specific erythroid inhibition.
            to distinguish from congenital causes of anemia, mainly Diamond-  Experimental and clinical observations have suggested that PRCA
            Blackfan  anemia  (DBA)  (Chapter  29).  Former  nosology  included   may also be mediated by CTLs, which specifically recognize and kill
            various terms such as erythrophthisis, chronic hypoplastic anemia, and   erythroid  precursors  similar  to  CTL-mediated  killing  of  cells  in
            pure red cell agenesis.                               aplastic anemia. Although such a T cell–mediated erythroid response
                                                                  is likely to be polyclonal, rare instances of T-cell large granular lym-
                                                                  phocyte  (T-LGL)  leukemia  associated  with  PRCA  or  erythroid
            ETIOLOGY AND CLASSIFICATION                           inhibition may represent an extreme form of the clonal continuum
                                                                  of CTL responses (see T-LGL-associated PRCA). In addition to CTLs
            Acquired  forms  of  PRCA  must  be  distinguished  from  congenital   expressing α/β T-cell receptors (TCRs), T cells with a γ/δ TCR can
            forms of PRCA, which usually manifest themselves early in life (see   mediate  PRCA. The  antigens/antigenic  peptides  triggering  such  a
            Chapter 29). Acquired PRCA occurring in childhood may be difficult   response have not been well described. Similarly, natural killer (NK)
            to distinguish from DBA. As an acquired disease, PRCA may be a   cells  have  also  been  implicated  in  mediating  cytotoxicity  directed
            primary  disorder  or  secondary  to  a  variety  of  systemic  diseases,   against  erythroid  precursors.  NK  cells,  like  γ/γ  T  lymphocytes
            including a number of hematologic malignancies (Table 32.1).  and  unlike  α/β  CTLs,  do  not  rely  on  major  histocompatibility
                                                                  complex  (MHC)–restricted  cytotoxicity,  but  may  use  killer-cell
                                                                  immunoglobulin-like receptors (KIRs). KIRs inhibit cytolysis when
            Pathogenesis                                          they encounter a cell bearing human leukocyte antigen (HLA) class
                                                                  I  molecules.  A  lack  of  appropriate  KIRs  may  predispose  cells  to
            The  inciting  events  in  the  development  of  PRCA  are  not  known.   increased attack by NK cells or γ/δ CTLs. Physiologic downregula-
            However, as with idiopathic aplastic anemia, viruses or exposure to   tion of KIRs has been implicated in the pathogenesis of PRCA in a
            chemicals can serve as potential triggers (Fig. 32.1). Theoretically a   patient with concomitant γ/δ T-LGL clonal proliferation. An alterna-
            viral infection could lead to depletion of erythroid precursors. Studies   tive  NK-cell  cytotoxic  mechanism  independent  of  KIR  has  been
            of B19 parvovirus (discussed later) suggest such an etiology. Because   reported in healthy individuals.
            hematopoietic stem cells are not affected by B19 parvovirus, myeloid   Peripheral Th lymphocyte polarization has been implicated in the
            cells and platelets are normally produced, and upon clearance of the   pathogenesis of PRCA. 56,57  Polarization toward the Th2 functional
            virus, normal erythroid production can resume. Similarly, in immune-  subtype during disease relapse and normalization of Th1/Th2 ratio
            mediated PRCA, the mechanism of erythroid inhibition may vary   after effective treatment has been reported in both monoclonal gam-
            and may include (1) antibodies to proteins specific to erythroblasts,   mopathy- and thymoma-associated PRCA.
            (2) direct cytotoxic T  lymphocyte (CTL)–mediated  killing  of  ery-
            throid precursors, and (3) production of soluble products by CTLs
            such as inhibitory or proapoptotic cytokines that directly affect the   PRIMARY PURE RED CELL APLASIA
            erythroid series.
              Historically, initial studies concentrated on examining the effects   Primary PRCA occurs in the absence of any underlying disorder. It
            of  soluble  serum  inhibitors  of  erythropoiesis. These  investigations   may be acute and self-limited or may be a chronic and refractory
            revealed a decline in erythroid colony formation in the presence of   condition.  Acute  forms  are  uncommon.  Most  cases  are  protracted
            patient serum or failure to induce erythroid colony formation in the   and chronic, unlike TEC, which is an acute and self-limited disorder.
            presence of erythropoietin. Such serum inhibitors can be found in   Most of the cases of classic primary PRCA are autoimmune in origin,
            40% of patients with PRCA. In 60% of patients, erythroid colony   but a significant proportion will remain idiopathic in origin in spite
            formation can be induced in vitro with hematopoietic growth factors.   of an exhaustive workup.

                                                                                                                 425
   500   501   502   503   504   505   506   507   508   509   510